Shigehiro Ohdo

Prof. Dr. Shigehiro Ohdo


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2001 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
SOShigehiro Ohdo
Shigehiro Ohdo
SKSatoru Koyanagi
Satoru Koyanagi
HSHinako Suyama
Hinako Suyama
SHShun Higuchi
Shun Higuchi
HAHironori Aramaki
Hironori Aramaki

31 July 2010 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
SOShigehiro Ohdo
Shigehiro Ohdo

14 October 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
SKSatoru Koyanagi
Satoru Koyanagi
NKNaoki Kusunose
Naoki Kusunose
MTMarie Taniguchi
Marie Taniguchi
TATakahiro Akamine
Takahiro Akamine
YKYuki Kanado
Yuki Kanado
SOShigehiro Ohdo
Shigehiro Ohdo
Diurnal variations in pain hypersensitivity are common in chronic pain disorders, but the underlying mechanisms are enigmatic. Here, we report that mechanical pain hypersensitivity in sciatic nerve-injured mice shows pronounced diurnal alterations, which critically depend on diurnal variations in glucocorticoids from the adrenal glands. Diurnal enhancement of pain hypersensitivity is mediated by glucocorticoid-induced enhancement of the extracellular release of ATP in the spinal cord, which stimulates purinergic receptors on microglia in the dorsal horn. We identify serum- and glucocorticoid-inducible kinase-1 (SGK-1) as the key molecule responsible for the glucocorticoid-enhanced release of ATP from astrocytes. SGK-1 protein levels in spinal astrocytes are increased in response to glucocorticoid stimuli and enhanced ATP release by opening the pannexin-1 hemichannels. Our findings reveal an unappreciated circadian machinery affecting pain hypersensitivity caused by peripheral nerve injury, thus opening up novel approaches to the management of chronic pain.

1 September 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SKSatoru Koyanagi
Satoru Koyanagi
AHAhmed Mohsen Hamdan
Ahmed Mohsen Hamdan
MHMichiko Horiguchi
Michiko Horiguchi
NKNaoki Kusunose
Naoki Kusunose
AOAkinori Okamoto
Akinori Okamoto
SOShigehiro Ohdo
Shigehiro Ohdo
Activating transcription factor (ATF)/cAMP-response element (CRE)-binding (CREB) proteins induce the CRE-mediated gene transcription depending on the cAMP stimulation. cAMP-dependent signaling oscillates in a circadian manner, which in turn also sustains core oscillation machinery of the circadian clock. Here, we show that among the ATF/CREB family proteins, ATF4 is essential for the circadian expression of the Period2 (Per2) gene, a key component of the circadian clock. Transcription of the Atf4 gene was regulated by core components of the circadian clock, and its expression exhibited circadian oscillation in mouse tissues as well as embryonic fibroblasts. ATF4 bound to the CRE of the Per2 promoter in a circadian time-dependent manner and periodically activated the transcription of the Per2 gene. Consequently, the oscillation of the Per2 expression was attenuated in embryonic cells prepared from Atf4-null mice. Furthermore, the loss of ATF4 also disrupted the rhythms in the expression of other clock genes. These results suggest that ATF4 is a component responsible for sustaining circadian oscillation of CRE-mediated gene expression and also constitute a molecular link connecting cAMP-dependent signaling to the circadian clock.

21 February 2022 in Molecular Cancer Research
Verified
Journal Article
Open access
PDF file
ATAkito Tsuruta
Akito Tsuruta
YSYuki Shiiba
Yuki Shiiba
NMNaoya Matsunaga
Naoya Matsunaga
MFMarina Fujimoto
Marina Fujimoto
YYYuya Yoshida
Yuya Yoshida
SOShigehiro Ohdo
Shigehiro Ohdo
Cancer cells have acquired several pathways to escape from host immunity in the tumor microenvironment. Programmed death 1 (PD-1) receptor and its ligand PD-L1 are involved in the key pathway of tumor immune escape, and immune checkpoint therapy targeting PD-1 and PD-L1 has been approved for the treatment of patients with certain types of malignancies. Although PD-1 is a well-characterized receptor on T cells, the immune checkpoint receptor is also expressed on tumor-associated macrophages (TAM), a major immune component of the tumor microenvironment. In this study, we found significant diurnal oscillation in the number of PD-1–expressing TAMs collected from B16/BL6 melanoma-bearing mice. The levels of Pdcd1 mRNA, encoding PD-1, in TAMs also fluctuated in a diurnal manner. Luciferase reporter and bioluminescence imaging analyses revealed that a NF-κB response element in the upstream region of the Pdcd1 gene is responsible for its diurnal expression. A circadian regulatory component, DEC2, whose expression in TAMs exhibited diurnal oscillation, periodically suppressed NF-κB–induced transactivation of the Pdcd1 gene, resulting in diurnal expression of PD-1 in TAMs. Furthermore, the antitumor efficacy of BMS-1, a small molecule inhibitor of PD-1/PD-L1, was enhanced by administering it at the time of day when PD-1 expression increased on TAMs. These findings suggest that identification of the diurnal expression of PD-1 on TAMs is useful for selecting the most appropriate time of day to administer PD-1/PD-L1 inhibitors. Implications: Selecting the most appropriate dosing time of PD-1/PD-L1 inhibitors may aid in developing cancer immunotherapy with higher efficacy.

13 May 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
YYYuya Yoshida
Yuya Yoshida
NMNaoya Matsunaga
Naoya Matsunaga
TNTakaharu Nakao
Takaharu Nakao
KHKengo Hamamura
Kengo Hamamura
HKHideaki Kondo
Hideaki Kondo
SOShigehiro Ohdo
Shigehiro Ohdo
Dysfunction of the circadian clock has been implicated in the pathogenesis of cardiovascular disease. The CLOCK protein is a core molecular component of the circadian oscillator, so that mice with a mutated Clock gene (Clk/Clk) exhibit abnormal rhythms in numerous physiological processes. However, here we report that chronic kidney disease (CKD)-induced cardiac inflammation and fibrosis are attenuated in Clk/Clk mice even though they have high blood pressure and increased serum angiotensin II levels. A search for the underlying cause of the attenuation of heart disorder in Clk/Clk mice with 5/6 nephrectomy (5/6Nx) led to identification of the monocytic expression of G protein-coupled receptor 68 (GPR68) as a risk factor of CKD-induced inflammation and fibrosis of heart. 5/6Nx induces the expression of GPR68 in circulating monocytes via altered CLOCK activation by increasing serum levels of retinol and its binding protein (RBP4). The high-GPR68-expressing monocytes have increased potential for producing inflammatory cytokines, and their cardiac infiltration under CKD conditions exacerbates inflammation and fibrosis of heart. Serum retinol and RBP4 levels in CKD patients are also sufficient to induce the expression of GPR68 in human monocytes. Our present study reveals an uncovered role of monocytic clock genes in CKD-induced heart failure.